3 key take-aways from BIO Patient and Health Advocacy Summit


Laura Mueller

Essential Insights contributor, healthcare writer

1. Biopharma companies and patient advocacy groups have a responsibility to work together on patients' behalf

2. Drug affordability and accessibility remains a top concern

3. Patient experience data must be a guiding force in drug development